We’re a medical device company in Women’s Health based in Switzerland developing next-generation devices for gynecology. Our flagship product - Carevix™ - is the world’s first suction cervical stabilizer clinically proven to reduce pain and bleeding associated with transcervical procedures commonly performed in gynecology e.g., IUD insertion. More than 90 million women worldwide are impacted by the tenaculum, an instrument invented over a century ago and considered the standard of care. Carevix is currently under development. Commercial release in expected for 2H2022 in the USA and selected European markets. At Aspivix, we are driven by our vision to make Gynecology. Now modern.